Cell MedX Corp. is a publicly traded research and development company (OTCPINK: CMXC) based in Carson City, NV. They specialize in the discovery, design, development, manufacture, and commercialization of clinical therapeutic and wellness products, with a focus on microcurrent therapy. Their compact and user-friendly microcurrent device, eBalance, is designed to empower individuals in managing their health and general well-being. Cell MedX is dedicated to advancing research in the field through device development, safety testing, and observational clinical studies, with promising results that warrant further investigation.
With a commitment to providing individuals with more control over their health, Cell MedX Corp. aims to obtain Class II Medical Device designation in both Canada and the USA. This will enable them to conduct additional research and development observational clinical studies, including the eBalance Experience Study, adhering to the standards of the Canadian Tri-Council Research Ethics Guidelines. As a leader in microcurrent therapeutic technology, Cell MedX Corp. is poised to shape the future of medicine and revolutionize the way individuals manage their well-being.
Generated from the website